Aino Karvonen

5.0k total citations · 1 hit paper
28 papers, 2.4k citations indexed

About

Aino Karvonen is a scholar working on Infectious Diseases, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Aino Karvonen has authored 28 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 13 papers in Epidemiology and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Aino Karvonen's work include Viral gastroenteritis research and epidemiology (17 papers), Viral Infections and Immunology Research (12 papers) and Hepatitis Viruses Studies and Epidemiology (11 papers). Aino Karvonen is often cited by papers focused on Viral gastroenteritis research and epidemiology (17 papers), Viral Infections and Immunology Research (12 papers) and Hepatitis Viruses Studies and Epidemiology (11 papers). Aino Karvonen collaborates with scholars based in Finland, Belgium and United States. Aino Karvonen's co-authors include Timo Vesikari, Astrid Borkowski, Alain Bouckenooghe, Volker Schuster, Silvia Damaso, Roman Prymula, Juan Carlos Tejedor Torres, Robert Cohen, François Meurice and Michele Pellegrini and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PEDIATRICS.

In The Last Decade

Aino Karvonen

28 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study

2007 510 citations Timo Vesikari, Aino Karvonen et al. profile →

Peers

Countries citing papers authored by Aino Karvonen

Since Specialization

Citations

This map shows the geographic impact of Aino Karvonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aino Karvonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aino Karvonen more than expected).

Fields of papers citing papers by Aino Karvonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aino Karvonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aino Karvonen. The network helps show where Aino Karvonen may publish in the future.

Co-authorship network of co-authors of Aino Karvonen

This figure shows the co-authorship network connecting the top 25 collaborators of Aino Karvonen. A scholar is included among the top collaborators of Aino Karvonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aino Karvonen. Aino Karvonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children 2011 ·New England Journal of Medicine ·Timo Vesikari, Markus Knuf, Peter Wutzler, Aino Karvonen, Dorothee Kieninger‐Baum, Heinz‐Josef Schmitt, Frank Baehner, Astrid Borkowski, Theodore F. Tsai, Ralf Clemens	230
2	Tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine is well tolerated and immunogenic when co-administered with measles–mumps–rubella–varicella vaccine during the second year of life: An open, randomized controlled trial 2011 ·Vaccine ·Timo Vesikari, Aino Karvonen, Véronique Bianco, Marie Van der Wielen, Jacqueline M. Miller	69
3	Immunogenicity of 10-Valent Pneumococcal Nontypeable Haemophilus Influenzae Protein D Conjugate Vaccine When Administered as Catch-up Vaccination to Children 7 Months to 5 Years of Age 2011 ·The Pediatric Infectious Disease Journal ·Timo Vesikari, Aino Karvonen, Tiina Korhonen, (unknown), Karita Sadeharju, (unknown), Ilse Dieussaert, Lode Schuerman	13
4	Safety and Immunogenicity of a Booster Dose of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine Coadministered With Measles-Mumps-Rubella-Varicella Vaccine in Children Aged 12 to 16 Months 2010 ·The Pediatric Infectious Disease Journal ·Timo Vesikari, Aino Karvonen, (unknown), Tiina Korhonen, Patricia Lommel, Paul Willems, Ilse Dieussaert, Lode Schuerman	31
5	Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study 2010 ·European Journal of Pediatrics ·Timo Vesikari, Aino Karvonen, Shannon Ferrante, Max Ciarlet	65
6	Sustained Efficacy of the Pentavalent Rotavirus Vaccine, RV5, up to 3.1 Years Following the Last Dose of Vaccine 2010 ·The Pediatric Infectious Disease Journal ·Timo Vesikari, Aino Karvonen, Shannon Ferrante, Barbara J. Kuter, Max Ciarlet	69
7	Norovirus gastroenteritis in young children receiving human rotavirus vaccine 2010 ·Scandinavian Journal of Infectious Diseases ·Shang‐Qin Zeng, Anne Halkosalo, Marjo Salminen, (unknown), Aino Karvonen, Timo Vesikari	13
8	MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination 2009 ·Vaccine ·Timo Vesikari, Nicola Groth, Aino Karvonen, Astrid Borkowski, Michele Pellegrini	115
9	Enhanced Immunogenicity of Seasonal Influenza Vaccines in Young Children Using MF59 Adjuvant 2009 ·The Pediatric Infectious Disease Journal ·Timo Vesikari, Michele Pellegrini, Aino Karvonen, Nicola Groth, Astrid Borkowski, Derek T. O’Hagan, Audino Podda	155
10	Efficacy of Inactivated Split‐Virus Influenza Vaccine against Culture‐Confirmed Influenza in Healthy Adults: A Prospective, Randomized, Placebo‐Controlled Trial 2009 ·The Journal of Infectious Diseases ·Jiřı́ Beran, Timo Vesikari, (unknown), Aino Karvonen, (unknown), (unknown), Pascale Van Belle, Mathieu Peeters, Bruce L. Innis, Jeanne‐Marie Devaster	53
11	CO-ADMINISTRATION OF PENTAVALENT ROTAVIRUS VACCINE, ROTATEQ®, WITH MENINGOCOCCAL GROUP C CONJUGATE VACCINE: IMMUNOGENICITY AND SAFETY 2008 ·Archives of Disease in Childhood ·Timo Vesikari, Aino Karvonen, Nicholas Kitchin, Martine Baudin, Stéphane Thomas, (unknown), Anne Fiquet	1
12	Efficacy of Pentavalent Rotavirus Vaccine, RotaTeq™, against Hospitalizations and Emergency Department Visits through the Third Year: The Finnish Extension Study 2008 ·International Journal of Infectious Diseases ·Timo Vesikari, Aino Karvonen, (unknown), Jody Lawrence, Max Ciarlet	2
13	A Randomized, Double-Blind Study of the Safety, Transmissibility and Phenotypic and Genotypic Stability of Cold-Adapted Influenza Virus Vaccine 2006 ·The Pediatric Infectious Disease Journal ·Timo Vesikari, Aino Karvonen, Tiina Korhonen, Kati Edelman, Raija Vainionpää, A. Salmi, Mélanie Saville, Iksung Cho, Ahmad Razmpour, Ruth Rappaport, Robert O’Neill, (unknown), William C. Gruber, Paul M. Mendelman, Bruce D. Forrest	83
14	Safety, Efficacy, and Immunogenicity of 2 Doses of Bovine‐Human (UK) and Rhesus–Rhesus‐Human Rotavirus Reassortant Tetravalent Vaccines in Finnish Children 2006 ·The Journal of Infectious Diseases ·Timo Vesikari, Aino Karvonen, (unknown), Shang‐Qin Zeng, Xiaoli Pang, Robert Kohberger, Bruce D. Forrest, Yasutaka Hoshino, Robert M. Chanock, Albert Z. Kapikian	51
15	Neonatal Administration of Rhesus Rotavirus Tetravalent Vaccine 2006 ·The Pediatric Infectious Disease Journal ·Timo Vesikari, Aino Karvonen, Bruce D. Forrest, Yasutaka Hoshino, Robert M. Chanock, Albert Z. Kapikian	18
16	Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants 2006 ·Vaccine ·Timo Vesikari, (unknown), (unknown), Michael J. Dallas, (unknown), Michelle G. Goveia, R. Ward, F. Schödel, Aino Karvonen, J. E. Drummond	102
17	A short report on highlights of world-wide development of RIX4414: An European experience 2005 ·Vaccine ·Timo Vesikari, Aino Karvonen, Leena Puustinen, (unknown), Shang‐Qin Zeng, A. Delem, Béatrice De Vos	7
18	A six‐fold gradient in the incidence of type 1 diabetes at the eastern border of Finland 2005 ·Annals of Medicine ·Anita Kondrashova, Antti Reunanen, A. Romanov, Aino Karvonen, Hanna Viskari, Timo Vesikari, Jorma Ilonen, Mikael Knip, Heikki Hyöty	118
19	Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants 2004 ·Vaccine ·Timo Vesikari, Aino Karvonen, Tiina Korhonen, Merimaaria Espo, E. Lebacq, Johannes Förster, Fred Zepp, A. Delem, Béatrice De Vos	112
20	Efficacy of RIX4414 Live Attenuated Human Rotavirus Vaccine in Finnish Infants 2004 ·The Pediatric Infectious Disease Journal ·Timo Vesikari, Aino Karvonen, Leena Puustinen, Shang‐Qin Zeng, (unknown), A. Delem, Béatrice De Vos	164

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact